We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Seeking Clues to MetLife (MET) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Read MoreHide Full Article
Wall Street analysts forecast that MetLife (MET - Free Report) will report quarterly earnings of $2.71 per share in its upcoming release, pointing to a year-over-year increase of 15.8%. It is anticipated that revenues will amount to $20.11 billion, exhibiting an increase of 12.3% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain MetLife metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Revenue- Premiums' of $12.11 billion. The estimate indicates a change of +14.7% from the prior-year quarter.
Analysts expect 'Revenue- Other Revenues' to come in at $767.89 million. The estimate points to a change of +6.1% from the year-ago quarter.
Analysts forecast 'Revenue- Net investment income' to reach $5.89 billion. The estimate indicates a change of -3.3% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Universal life and investment-type product policy fees' will reach $1.35 billion. The estimate suggests a change of +7.9% year over year.
Analysts predict that the 'Total Adjusted Revenue- Latin America' will reach $2.40 billion. The estimate indicates a year-over-year change of +15.7%.
The combined assessment of analysts suggests that 'Adjusted Revenue- Corporate & other- Net investment income' will likely reach $986.69 million. The estimate points to a change of +1309.6% from the year-ago quarter.
Analysts' assessment points toward 'Total Adjusted Revenue- EMEA' reaching $864.07 million. The estimate indicates a change of +8.8% from the prior-year quarter.
According to the collective judgment of analysts, 'Total Adjusted Revenue- Asia' should come in at $3.29 billion. The estimate indicates a year-over-year change of +6.2%.
Based on the collective assessment of analysts, 'Adjusted Revenue- Asia- Net investment income' should arrive at $1.53 billion. The estimate suggests a change of +11.1% year over year.
It is projected by analysts that the 'Adjusted Revenue- EMEA- Net investment income' will reach $69.44 million. The estimate indicates a change of +3.6% from the prior-year quarter.
The consensus estimate for 'Adjusted Revenue- Latin America- Net investment income' stands at $552.49 million. The estimate indicates a year-over-year change of +33.5%.
The average prediction of analysts places 'Adjusted Revenue- Asia- Other Revenues' at $19.18 million. The estimate indicates a year-over-year change of -4.1%.
MetLife shares have witnessed a change of +6.9% in the past month, in contrast to the Zacks S&P 500 composite's +0.7% move. With a Zacks Rank #3 (Hold), MET is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
View the Zacks #1 Rank List
Image: Bigstock
Seeking Clues to MetLife (MET) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
Wall Street analysts forecast that MetLife (MET - Free Report) will report quarterly earnings of $2.71 per share in its upcoming release, pointing to a year-over-year increase of 15.8%. It is anticipated that revenues will amount to $20.11 billion, exhibiting an increase of 12.3% compared to the year-ago quarter.
The consensus EPS estimate for the quarter has been revised 0.8% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
In light of this perspective, let's dive into the average estimates of certain MetLife metrics that are commonly tracked and forecasted by Wall Street analysts.
The collective assessment of analysts points to an estimated 'Revenue- Premiums' of $12.11 billion. The estimate indicates a change of +14.7% from the prior-year quarter.
Analysts expect 'Revenue- Other Revenues' to come in at $767.89 million. The estimate points to a change of +6.1% from the year-ago quarter.
Analysts forecast 'Revenue- Net investment income' to reach $5.89 billion. The estimate indicates a change of -3.3% from the prior-year quarter.
The consensus among analysts is that 'Revenue- Universal life and investment-type product policy fees' will reach $1.35 billion. The estimate suggests a change of +7.9% year over year.
Analysts predict that the 'Total Adjusted Revenue- Latin America' will reach $2.40 billion. The estimate indicates a year-over-year change of +15.7%.
The combined assessment of analysts suggests that 'Adjusted Revenue- Corporate & other- Net investment income' will likely reach $986.69 million. The estimate points to a change of +1309.6% from the year-ago quarter.
Analysts' assessment points toward 'Total Adjusted Revenue- EMEA' reaching $864.07 million. The estimate indicates a change of +8.8% from the prior-year quarter.
According to the collective judgment of analysts, 'Total Adjusted Revenue- Asia' should come in at $3.29 billion. The estimate indicates a year-over-year change of +6.2%.
Based on the collective assessment of analysts, 'Adjusted Revenue- Asia- Net investment income' should arrive at $1.53 billion. The estimate suggests a change of +11.1% year over year.
It is projected by analysts that the 'Adjusted Revenue- EMEA- Net investment income' will reach $69.44 million. The estimate indicates a change of +3.6% from the prior-year quarter.
The consensus estimate for 'Adjusted Revenue- Latin America- Net investment income' stands at $552.49 million. The estimate indicates a year-over-year change of +33.5%.
The average prediction of analysts places 'Adjusted Revenue- Asia- Other Revenues' at $19.18 million. The estimate indicates a year-over-year change of -4.1%.
View all Key Company Metrics for MetLife here>>>MetLife shares have witnessed a change of +6.9% in the past month, in contrast to the Zacks S&P 500 composite's +0.7% move. With a Zacks Rank #3 (Hold), MET is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .